Japan should reject WTO proposal to weaken COVID patents

Government's pandemic preparation plan depends on commitments from drugmakers

Avatar
202211009 COVID vaccine Kenya.jpg

A woman receives a COVID-19 vaccine in Kimana, Kenya, in 2021: Weakening intellectual property protections will not increase the availability of drugs in developing countries. © AP

Thomas Cueni is director general of the International Federation of Pharmaceutical Manufacturers and Associations, which is based in Geneva.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.